Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.
Issue link: http://gen.epubxp.com/i/716943
40 | SEPTEMBER 1, 2016 | GENengnews.com | Genetic Engineering & Biotechnology News September > September 7–9 Biobanking Congress to be held in Baltimore. Web: www.healthtech.com/biobanking. > September 12–14 iForum 2016: Differentiated Human iPS Cell Innovations and Applications to be held in Philadelphia. Web: iforum.community. > September 14–17 Proteomics in Cell Bi- ology and Disease Mechanisms to be held in Heidelberg. Web: www.embl.de/training. > September 25–28 The Genomics of Common Diseases to be held in Baltimore. Web: registration.hinxton.wellcome.ac.uk. > September 26–28 NGS, Single Cell Analysis, Single Molecule Analysis & Mass Spec to be held in San Diego. Web: selectbiosciences.com. > September 26–30 Mechanisms of Aging to be held in Cold Spring Harbor, NY. Web: meetings.cshl.edu. > September 29–30 Liquid Biopsies and Minimally-Invasive Diagnostics to be held in San Diego. Web: selectbiosciences.com. > September 29–30 Neuroscience R&D; Technologies Conference to be held in London. Web: www.mnmconferences.com. October > October 3–7 Real-Time, Quantitative and Digital PCR to be held in Germantown, MD. Web: www.biotrac.com. > October 4–5 Bioimaging Asia 2016– Metabolic, Neuro, Cancer & Cardiovascular to be held in Singapore. Web: selectbiosciences.com. > October 5–7 Next Generation Cancer Immuno Therapies to be held in Boston. Web: www.ibclifesciences.com. > October 6–7 Biomarker Clinical Development & Clinical Trials to be held in Berlin. Web: www.gtcbio.com. > October 11 iForum 2016 Europe: Differentiated Human iPS Cell Innovations and Applications to be held in Paris. Web: iforum.community. > October 11–12 Next Generation Sequencing Asia Congress to be held in Singapore. Web: www.ngsasia-congress.com. > October 13 New Frontiers in 3D Cell Culture-Based Screening Technologies to be held in Baltimore. Web: www.insphero. com/new-frontiers-in-3d-conference. > October 18–22 American Society of Human Genetics to be held in Vancouver, Canada. Web: www.ashg.org. > October 25–27 tranSMART 2016 Annual Meeting to be held in La Jolla. Web: transmartfoundation.org. > October 31–November 4 PEGS Europe to be held in Lisbon. Web: www.pegsummiteurope.com. November > November 1–2 Cancer Immunotherapy and Biofluid Biopsies to be held in Boston. Web: selectbiosciences.com. > November 3–4 Cell Culture & Bioprocess- ing Congress to be held in London. Web: www.cellculture-congress.com. > November 7–9 Novel Cancer Therapeu- tics Summit to be held in San Francisco. Web: www.gtcbio.com. > November 8–9 Lab Automation & Robotics to be held in Berlin. Web: selectbiosciences.com. > November 10–11 Next Generation Se- quencing Congress to be held in London. Web: www.nextgenerationsequencing-con- gress.com. > November 10–12 AMP to be held in Charlotte, SC. Web: www.amp.org. > November 12–16 Society for Neuroscience to be held in San Diego. Web: www.sfn.org. C O M P A N Y I N D E X Aber Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Acea Biosciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Actavis Generics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Active Motif . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,22,38 Adicet Bio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Allergan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Alnylam Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Amyris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Applikon Biotechnology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Aquila Biolabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Assurex Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Astellas Pharma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Asynt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Avara Norman Pharmaceutical Services . . . . . . . . . . . . . . . . . . . . . . . 26 Bamboo Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Banyan Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Biogen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26 Bristol-Myers Squibb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 BugLab . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24,30 Constellation Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Editas Medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Epigentek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 Eureka Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Fluid-Screen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Fogale Nanotech . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 GE Healthcare Life Sciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Genentech . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,22 GlaxoSmithKline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Hamilton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 HEMCO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Illumina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Inovio Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Integral Molecular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 Jackson Laboratory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Juno Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Lewa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Luminex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 mAb Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Malvern Instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 MilliporeSigma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10,39 Myriad Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 PerkinElmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Personal Genome Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Pfizer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Phenomenex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 PreSens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26,28 Quanterix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Regeneron Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Repositive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Resverlogix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Roche . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Rubicon Genomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Sartorius Stedim Biotech . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24,38 Scynex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Seattle Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37 SomaGenics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Syngene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Syrris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Takeda Pharmaceutical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Telesta Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Tetraphase Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Teva . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Theranos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Thermo Fisher Scientific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26,39 Tokai Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 vTv Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Xpand Biotechnology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Zenith Epigenetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Zeta Biopharma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Zymo Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 CALENDAR F r e e W e b i n a r Advancing GPCR Drug Discovery through Allosteric Modulation View it Now! On Demand Sponsored by Cisbio FREE REGISTRATION GENengnews.com/allosteric Send your Upcoming Events to calendar@GENengnews.com F r e e W e b i n a r Analyzing Complex N-Glycans Using Online 2D-LC View it Now! On Demand Sponsored by Agilent FREE REGISTRATION GENengnews.com/2DLC F r e e W e b i n a r Simplifying Protein Quantification Workflows View it Now! On Demand Sponsored by Waters FREE REGISTRATION GENengnews.com/quantification October 3–4 Single Cell Analysis USA to be held in Boston Population averages can be misleading, depicting homogeneity where heterogeneity is rife. Even small groups of seemingly uniform cells harbor variations in gene activity, protein expression, signaling behavior, and so on. To appreciate such heterogeneity, don't settle for average in cell analysis—and not in cell analysis conferences, either. One conference in particular, Single Cell Analysis USA, will provide coverage that is both wide and deep. On the agenda: omics case studies, single-cell techniques (sample handling, microfluidics, PCR, high-throughput sequencing), clinical applications, and bioinformatics challenges. Besides being an occasion to encounter 250 delegates representing academic institutions, clinical research institutions, and pharmaceutical and biotech companies, this conference will be co-located with Next Generation Sequencing USA. Register Today www.singlecellusa-congress.com. M E E T I N G H I G H L I G H T